Status:
COMPLETED
Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Pediatric Cancer
Survivorship
Eligibility:
All Genders
9-18 years
Brief Summary
This study aims to fill the gaps in knowledge regarding the effects of cancer and its treatment on Hong Kong Chinese paediatric cancer survivors, especially during the transition period, to further ca...
Detailed Description
Objectives: Although increasing attention has been devoted to the development of paediatric cancer survivorship programmes, most of these studies have originated in Western countries. Given the cultur...
Eligibility Criteria
Inclusion
- able to speak Cantonese and read Chinese
- aged between 9 and 18 years of age
- Should have completed cancer treatment between 2 months and 2 years earlier
Exclusion
- Children who received a diagnosis and completed treatment before the age of 9 will be excluded as they might have vague memories of the course of cancer and may have limited verbal and cognitive ability to express themselves
- Children of exclude parents will be exclueded
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05355779
Start Date
August 1 2022
End Date
December 1 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Children's Hospital
Hong Kong, Hong Kong